Vascular mechanisms of increased arterial pressure in preeclampsia: Lessons from animal models

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Khalil, Raouf A ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelium; Hypertension; Pregnancy; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; CALCIUM; CYCLIC AMP; CYCLIC GMP; ENDOTHELIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; PROSTACYCLIN; PROTEIN KINASE C; THROMBOXANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; CYTOTROPHOBLAST; ENZYME ACTIVITY; FEMALE; HEMODYNAMICS; HUMAN; HYPOXIA; INTRAUTERINE PRESSURE; ISCHEMIA; MYOFILAMENT; NONHUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SMOOTH MUSCLE CONTRACTION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0036333677     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00762.2001     Document Type: Review

References (173)

1. Role of neuronal nitric oxide synthase in mediating renal hemodynamic changes during pregnancy
2. Enhanced endothelium-derived relaxing factor activity in pregnant, spontaneously hypertensive rats
3. Tumor necrosis factor-α-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression
4. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide
5. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats
6. Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure
7. Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy
8. Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells
9. Preeclampsia: New thoughts on an ancient problem
10. Pathophysiology of preeclampsia
11. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin
12. Plasma from women with preeclampsia increases endothelial cell nitric oxide production
13. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia
14. cGMP antagonizes angiotensin-mediated phosphatidylcholine hydrolysis and C kinase activation in mesangial cells
15. High-salt diet enhances vascular reactivity in pregnant rats with normal and reduced uterine perfusion pressure
16. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat
17. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: Studies in the rat and implications for preeclampsia
18. Expression of inflammatory cytokines in placentas from women with preeclampsia
19. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance
20. Classification of hypertension in pregnancy
21. Low-dose aspirin to prevent preeclampsia in women at high risk
22. Association of maternal endothelial dysfunction with preeclampsia
23. Trophoblast deportation in pre-eclamptic pregnancy
24. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1
25. Plasma endothelin levels in preeclampsia: Elevation and correlation with uric acid levels and renal impairment
26. Possible mechanisms for changes in renal hemodynamics during pregnancy: Studies from animal models
27. Animal models of pre-eclampsia: Do they exist?
28. Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy
29. Placental cytokines and the pathogenesis of preeclampsia
30. Nitric oxide synthase activity in placentae from women with pre-eclampsia
31. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats
32. Identification of increased nitric oxide biosynthesis during pregnancy in rats
33. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet
34. Circulating levels of immunoreactive cytokines in women with preeclampsia
35. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats
36. G-monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats
37. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: A meta-analysis(1)
38. Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat
39. 2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats
40. Nitric oxide metabolites in normal human pregnancy and pre-eclampsia
41. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats
42. Phorbol ester-induced contraction of arterial smooth muscle and inhibition of alpha-adrenergic response
43. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia
44. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat
45. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin
46. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women
47. Decreased endothelium-dependent vascular relaxation via the NO cGMP pathway during TNFα-induced hypertension in pregnant rats
48. Renal hemodynamics and tubular function normal human pregnancy
49. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor
50. Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret
51. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass
52. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia
53. Etiology and pathogenesis of preeclampsia: Current concepts
54. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall
55. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: Systematic review
56. Renal hemodynamics and volume homeostasis in pregnancy
57. Maternal hemodynamics in normal and preeclamptic pregnancies: A longitudinal study
58. A role for brain angiotensin II in experimental pregnancy-induced hypertension in laboratory rats
59. Long-term nitric oxide blockade in the pregnant rat: Effects on blood pressure and plasma levels of endothelin-1
60. A new animal model for human preeclampsia: Ultra-low-dose endotoxin infusion in pregnant rats
61. Evidence for declining extracellular calcium uptake and protein kinase C activity in uterine arterial smooth muscle during gestation in gilts
62. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension
63. Thromboxane A2 synthesis in pregnancy-induced hypertension
64. Preeclampsia: A review of the role of prostaglandins
65. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation
66. Preeclampsia and related disorders. Clinical aspects and relevance of endothelin and nitric oxide
67. Pathophysiology of preeclampsia
68. The role of endothelium-derived hyperpolarizing factor in the regulation of the uterine circulation in pregnant rats
69. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats
70. A study of angiotensin II pressor response throughout primigravid pregnancy
71. Invasive cytotrophoblast apoptosis in pre-eclampsia
72. Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: An important role for endothelium-derived hyperpolarizing factor (EDHF)
73. Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet
74. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding
75. Pathophysiology of pregnancy-induced hypertension
76. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction
77. Endothelin stimulates diacylglycerol accumulation and activates protein kinase C in cultured vascular smooth muscle cells
78. Inducible change in the behavior of resistance arteries from circulating factor in preeclampsia: An effect specific to myometrial vessels from pregnant women
79. The preliminary characterization of a vasoactive circulating factor(s) in preeclampsia
80. Placental expression and serum levels of cytokeratin-18 are increased in women with preeclampsia
81. Cytoplasmic free calcium, myosin light chain phosphorylation, and force in phasic and tonic smooth muscle
82. Mechanisms of smooth muscle contraction
83. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation
84. Intracellular calcium levels in phorbol ester-induced contractions of vascular muscle
85. 2+ entry during coronary artery contraction by vasoactive eicosanoids
86. 2+-insensitive vascular protein kinase C during pregnancy and NOS inhibition
87. Preconditioning of coronary artery against vasoconstriction by endothelin-1 and prostaglandin F2α during repeated downregulation of epsilon-protein kinase C
88. Pregnancy-associated reduction in vascular protein kinase C activity rebounds during inhibition of NO synthesis
89. Signal transduction by protein kinase C in mammalian cells
90. Purification and characterization of a complex from placental syncytiotrophoblast microvillous membranes which inhibits the proliferation of human umbilical vein endothelial cells
91. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats
92. i threshold for translocation of the alpha-protein kinase C isoform
93. 2+independent isoforms of protein kinase C differentially translocate in smooth muscle
94. +
95. Mechanisms of calcium mobilization and homeostasis in vascular smooth muscle and their relevance to hypertension
96. Sustained contraction of vascular smooth muscle: Calcium influx or C-kinase activation?
97. Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia
98. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia
99. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction
100. Endothelium-derived relaxing factor inhibits the endothelin-1-induced increase in protein kinase C activity in rat aorta
101. Hypertension in pregnancy
102. The kidney and hypertension in pregnancy: Twenty exciting years
103. Renal physiology and disease in pregnancy
104. Redistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta
105. Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits
106. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia
107. Protein kinase C in uterine and systemic arteries during ovarian cycle and pregnancy
108. Transcriptional regulation of the endothelin-1 gene by TNF-alpha
109. Hypotensive effect of endothelin-1 in nitric oxide-deprived, hypertensive pregnant rats
110. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration
111. Nitric oxide biosynthesis during pregnancy: Implications for circulatory changes
112. ω-nitro L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy induced refractoriness to vasopressor agents
113. Toth, and Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation
114. Nitric oxide, the endothelium, pregnancy and pre-eclampsia
115. i signaling in renal arterial smooth muscle cells of pregnant rat is enhanced during inhibition of NOS
116. Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery
117. Renal vascular walls in patients with preeclampsia superimposed on essential hypertension
118. Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy
119. Preeclamptic serum enhances endothelin-converting enzyme expression in cultured endothelial cells
120. 2+ sensitivity in norepinephrine-activated vascular smooth muscle
121. Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage
122. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
123. Maternal plasma level of endothelin is increased in preeclampsia
124. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia
125. Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats
126. Cytokines and endothelial cell biology
127. Animal models of preeclampsia
128. Endothelin receptors and calcium signaling
129. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
130. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia
131. TPA-induced contraction of isolated rabbit vascular smooth muscle
132. 2+] sensitivity of myosin phosphorylation in intact swine arterial smooth muscle
133. 2+] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle
134. Preeclampsia: What we know and what we do not know
135. Endothelial dysfunction in preeclampsia
136. Pathogenesis and genetics of pre-eclampsia
137. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia
138. Preeclampsia: An endothelial cell disorder
139. Serial study of factors influencing changes in cardiac output during human pregnancy
140. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells
141. Modulation of calcium mobilization in aortic rings of pregnant rats: Contribution of extracellular calcium and of voltage-operated calcium channels
142. Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography
143. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986
144. Atrial natriuretic peptides inhibit protein kinase C activation in rat aortic smooth muscle
145. Endothelin and endothelin antagonists in hypertension
146. Vascular biology of endothelin
147. The role of nitric oxide in the pathogenesis of preeclampsia
148. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels
149. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, preeclampsia and eclampsia
150. Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy
151. Nitric oxide and pregnancy
152. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II
153. Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor beta, and fibronectin synthesis induced by thromboxane
154. Role of protein kinase C in the endothelin-induced contraction in the rabbit saphenous vein
155. 2+-independent change in phosphorylation of the myosin light chain during relaxation of ferret aorta by vasodilators
156. Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction
157. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies
158. Elevated levels of S-nitrosoalbumin in preeclampsia plasma
159. Vascular biology. Old-timer makes a come-back
160. Endothelial function in myometrial resistance arteries of normal pregnant women perfused with syncytiotrophoblast microvillous membranes
161. Vascular reactivity in preeclampsia
162. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia
163. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation
164. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia
165. Nitric oxide-mediated vasodilation in human pregnancy
166. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women
167. Importance of prostaglandins in hypertension during reduced uteroplacental perfusion pressure
168. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia
169. Anti-endothelial cell antibody in preeclampsia: Clinical findings and serum cytotoxicity to endothelial cell
170. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants
171. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
172. NHBPEP report on high blood pressure in pregnancy: A summary for family physicians
173. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts